Cargando…
Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats
BACKGROUND: Pioglitazone is a thiazolidinedione (TZD) insulin sensitizer approved for use in human type 2 diabetes mellitus. Therapeutic options for diabetes in cats are limited. OBJECTIVE: To evaluate the effects of pioglitazone in obese cats, which are predisposed to insulin resistance, to assess...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895531/ https://www.ncbi.nlm.nih.gov/pubmed/24592408 http://dx.doi.org/10.1111/jvim.12255 |